AXON

Axon Enterprise, Inc.

Updated Jul 17, 2026

Industrials · Aerospace & Defense · United States · Stock

38.0High RiskMonitor Only

Score Breakdown

Scored for Aggressive Growth profile

Growth11.0 / 20
Profitability4.4 / 20
Financial Health14.0 / 20
Fundamental Momentum11.4 / 20
Dividend Safety0.0 / 20
Theme Exposure0.0 / 20
Model Score38.0 / 100

Sub-scores are 0–20 each; Model Score is weighted by your selected investment goal. How it works →

Why Ranked Here

  • The composite score of 38.0 reflects a mixed sub-score profile in which only one component — financial health at 14.0 — scores in a range that would typically be considered strong, while profitability at 4.4 and dividend at 0.0 create significant drag on the total.
  • The growth and momentum sub-scores (11.0 and 11.4 respectively) are moderate rather than high, suggesting that while Axon is improving, the rate or consistency of growth and earnings advancement captured in the FY 2025 10-K did not qualify for top-tier scoring.
  • The zero scores across both dividend and theme sub-components mean that 40 possible points in the model are entirely uncaptured by Axon's filing data, mathematically anchoring the total score well below the midpoint.

Why Not Higher

  • The profitability sub-score of 4.4 out of 20 is the single largest constraint on the total score, and until Axon's net margin, operating margin, and return on assets improve materially in subsequent 10-K filings, this component will continue to suppress the overall model output.
  • The complete absence of dividend-related metrics and the failure to register macro theme exposure in the scoring model means Axon forfeits up to 40 points of total score potential — points that better-rounded research candidates would partially or fully capture.

Data Confidence

7 / 10

High — most data fields present

Research Summary

AI-generated analysis reflects data and conditions as of the report date shown above. Verify any specific figures through primary sources before acting on this analysis.

Axon Enterprise, Inc. is a U.S.-based technology and defense company operating within the Aerospace & Defense segment of the Industrials sector. It is best known for its TASER conducted energy weapons, body-worn cameras, and its cloud-based evidence management platform (Axon Evidence), all of which are sold primarily to law enforcement agencies, military customers, and increasingly to enterprise and international clients. The company has positioned itself at the intersection of public safety hardware and software-as-a-service, generating recurring revenue through subscription-based software alongside hardware refresh cycles. The scoring model assigns Axon a composite score of 38.0/100 under its FY 2025 10-K data, reflecting a company that demonstrates measurable operational momentum and revenue growth but is constrained by weak profitability metrics and an absence of dividend income or identifiable macro theme exposure in the scoring framework. The growth sub-score of 11.0 and momentum sub-score of 11.4 confirm that Axon is expanding its top line and showing quarterly improvement in revenues and earnings, but the profitability sub-score of just 4.4 signals that net margins, operating margins, and return on assets remain thin relative to peers — a common characteristic of high-investment-phase SaaS-hardware hybrid businesses. The financial health sub-score of 14.0 is the strongest individual component, suggesting the balance sheet carries manageable leverage and adequate interest coverage, but this alone is insufficient to push the total score materially higher. The central research tradeoff for Axon is between a credible, high-growth business narrative — sustained by its dominant position in law enforcement tech and growing software attach rates — and current profitability metrics that are too modest to generate strong composite model scores. The zero scores on dividend and theme sub-components further depress the total, making this a research candidate best evaluated within an aggressive growth context, where the 46.5 best-profile score reflects its strongest relative positioning.

Plain English

Axon makes the TASER and body camera systems used by police departments, plus the cloud software that stores and manages all that footage. The score of 38.0 out of 100 tells a researcher that while the company is growing and its balance sheet looks reasonably healthy, it isn't yet consistently converting that growth into strong profits — making it a high-risk research candidate suited mainly for those comfortable with aggressive growth profiles. The High risk rating reflects the combination of thin margins, no dividend, and the heavy investment Axon is still making to scale its software platform and expand internationally.

Bull Case vs. Bear Case

Bull Case

  • The financial health sub-score of 14.0 out of 20 indicates that Axon carries manageable leverage and sufficient interest coverage relative to its debt obligations, providing a stable foundation from which to fund continued platform expansion.
  • The momentum sub-score of 11.4 reflects measurable quarter-over-quarter improvement in revenues, earnings, or margins as reported in the FY 2025 10-K, suggesting the company's operating trajectory is moving in the right direction.
  • The growth sub-score of 11.0 confirms that Axon is generating meaningful year-over-year increases across revenue, net income, or EPS lines, consistent with a company in an active expansion phase within its law enforcement and enterprise markets.

Bear Case

  • The profitability sub-score of just 4.4 out of 20 is the weakest substantive component in the model, indicating that net margin, operating margin, and return on assets derived from the 10-K filings remain well below levels that would characterize an efficiently profitable business.
  • The dividend sub-score of 0.0 confirms that Axon pays no dividend and has no FCF payout history, meaning researchers focused on income generation or capital return efficiency will find no support from this dimension of the model.
  • The theme sub-score of 0.0 indicates that the scoring model did not identify sufficient macro theme exposure from the 10-K filing data, limiting the company's score uplift from structural tailwinds that would otherwise strengthen its research profile.

What Could Change the Picture

Bullish Triggers

  • A significant improvement in the profitability sub-score in a future 10-K filing — driven by expanding net margins or stronger return on assets as Axon's software subscription base scales — would be the most impactful single data change to improve the composite model score.
  • Acceleration in the momentum sub-score, reflecting steeper quarter-over-quarter margin or earnings improvement rather than revenue growth alone, would signal that Axon is entering a phase of operating leverage and would strengthen the research case.

Bearish Triggers

  • A deterioration in the financial health sub-score — currently the strongest component at 14.0 — due to increased leverage, weaker interest coverage, or a declining balance sheet position would remove the primary pillar supporting Axon's current model score.
  • A reversal in the momentum sub-score, reflecting slowing or declining quarterly revenue and earnings metrics in a subsequent 10-K, would suggest the current growth trajectory is stalling and would further weaken the already modest composite score.

Red Flags

  • The profitability sub-score of 4.4 is notably low for a company of Axon's scale and revenue trajectory, raising a data-supported concern that operating costs and investment spending are significantly outpacing margin improvement despite top-line growth.

Risk Profile

High Risk

The High risk rating for Axon reflects the combination of thin profitability metrics captured in the FY 2025 10-K, an absence of dividend or income cushion, and the company's continued investment-heavy posture as it scales its SaaS platform and expands internationally — all of which create meaningful variability in forward financial outcomes. Researchers should note that this risk profile is consistent with the aggressive growth goal designation, where short-term financial results may be volatile relative to long-term platform value.

Key Catalysts to Watch

The primary catalyst to monitor from a filing-data perspective is whether Axon's profitability metrics — net margin, operating margin, and ROA — begin to improve materially in future 10-K filings as its recurring software subscription revenue grows as a proportion of total revenue. Secondary to this, any evidence of improved operating leverage showing up in quarterly momentum metrics within subsequent annual filings would be a meaningful positive signal for the model score.

This report is for educational and research purposes only. It does not constitute financial, investment, legal, or tax advice — always conduct your own due diligence before making investment decisions.